Literature DB >> 35613056

Structural control of fibrin bioactivity by mechanical deformation.

Sachin Kumar1,2,3, Yujen Wang1, Mohammadhasan Hedayati1, Frederik Fleissner4, Manuel K Rausch1,5,6, Sapun H Parekh1,4.   

Abstract

Fibrin is the fibrous protein network that comprises blood clots; it is uniquely capable of bearing very large tensile strains (up to 200%) due to multiscale force accommodation mechanisms. Fibrin is also a biochemical scaffold for numerous enzymes and blood factors. The biomechanics and biochemistry of fibrin have been independently studied. However, comparatively little is known about how fibrin biomechanics and biochemistry are coupled: how does fibrin deformation influence its biochemistry? In this study, we show that mechanically induced protein structural changes in fibrin affect fibrin biochemistry. We find that tensile deformation of fibrin leads to molecular structural transitions of α-helices to β-sheets, which reduced binding of tissue plasminogen activator (tPA), an enzyme that initiates fibrin lysis. Moreover, binding of tPA and Thioflavin T, a commonly used β-sheet marker, were mutually exclusive, further demonstrating the mechano-chemical control of fibrin biochemistry. Finally, we demonstrate that structural changes in fibrin suppressed the biological activity of platelets on mechanically strained fibrin due to reduced αIIbβ3 integrin binding. Our work shows that mechanical strain regulates fibrin molecular structure and biological activity in an elegant mechano-chemical feedback loop, which possibly extends to other fibrous biopolymers.

Entities:  

Keywords:  extracellular matrix; fibrin; mechanochemistry; structure-function

Mesh:

Substances:

Year:  2022        PMID: 35613056      PMCID: PMC9295804          DOI: 10.1073/pnas.2117675119

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   12.779


  49 in total

1.  The sequence gamma-(312-324) is a fibrin-specific epitope.

Authors:  W J Schielen; H P Adams; K van Leuven; M Voskuilen; G I Tesser; W Nieuwenhuizen
Journal:  Blood       Date:  1991-05-15       Impact factor: 22.113

2.  Biophysics. Enigmas of blood clot elasticity.

Authors:  John W Weisel
Journal:  Science       Date:  2008-04-25       Impact factor: 47.728

3.  Stretching single fibrin fibers hampers their lysis.

Authors:  Wei Li; Tomas Lucioni; Rongzhong Li; Keith Bonin; Samuel S Cho; Martin Guthold
Journal:  Acta Biomater       Date:  2017-07-25       Impact factor: 8.947

4.  Tissue-type plasminogen activator is a multiligand cross-beta structure receptor.

Authors:  Onno Kranenburg; Barend Bouma; Loes M J Kroon-Batenburg; Arie Reijerkerk; Ya-Ping Wu; Emile E Voest; Martijn F B G Gebbink
Journal:  Curr Biol       Date:  2002-10-29       Impact factor: 10.834

Review 5.  Fibrin-mediated plasminogen activation.

Authors:  W Nieuwenhuizen
Journal:  Ann N Y Acad Sci       Date:  2001       Impact factor: 5.691

Review 6.  Molecular mechanism of Thioflavin-T binding to amyloid fibrils.

Authors:  Matthew Biancalana; Shohei Koide
Journal:  Biochim Biophys Acta       Date:  2010-04-22

7.  Multiscale mechanics of fibrin polymer: gel stretching with protein unfolding and loss of water.

Authors:  André E X Brown; Rustem I Litvinov; Dennis E Discher; Prashant K Purohit; John W Weisel
Journal:  Science       Date:  2009-08-07       Impact factor: 47.728

8.  Plasminogen on the surfaces of fibrin clots prevents adhesion of leukocytes and platelets.

Authors:  V K Lishko; I S Yermolenko; T P Ugarova
Journal:  J Thromb Haemost       Date:  2009-01-22       Impact factor: 5.824

9.  The α-helix to β-sheet transition in stretched and compressed hydrated fibrin clots.

Authors:  Rustem I Litvinov; Dzhigangir A Faizullin; Yuriy F Zuev; John W Weisel
Journal:  Biophys J       Date:  2012-09-05       Impact factor: 4.033

10.  Quantitative structural mechanobiology of platelet-driven blood clot contraction.

Authors:  Oleg V Kim; Rustem I Litvinov; Mark S Alber; John W Weisel
Journal:  Nat Commun       Date:  2017-11-02       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.